Scripta, Mark Cuban Cost Plus Drug Company Partner Up on Drug Price Transparency
The agreement provides Scripta patients with another option when purchasing medication.
Scripta Insights, a digital health company that develops pharmacy navigation solutions for self-insured employers, health plans and their members, is teaming up with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), in order to make prescription drugs more accessible and affordable to patients.
Specifically, Scripta is working to integrate Cost Plus Drugs’ discounted pricing into its proprietary “Med Mapper,” adding to its portfolio of savings strategies that help members save money on their out-of-pocket costs. Through its member app and portal, Scripta provides members with personalized savings reports that reveal all their medication options, whether that’s switching to an alternative prescription available through their health plan or a cash pay option like Cost Plus Drugs.
“We are excited to work with Scripta Insights to bring lower prescription drug prices to consumers,” says Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “Cost Plus Drugs and Scripta Insights share a common goal of providing consumers the lowest possible price for their prescription medications. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
